Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

p63 is essential for controlling epithelial stem cells and tissue health.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Mutations in the spike protein affect drug binding and effectiveness.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New drug delivery methods can make natural compounds more effective and stable.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Natural products can help overcome cancer drug resistance.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.